MNKD

MannKind Corporation

6 catalysts on file

MNKD

MannKind Corporation

PDUFA Confirmed

Afrezza

type 1 diabetes (pediatric)

129d ago ~ May 29, 2026

SEC 8-K verified 3mo ago

Countdown card →

MNKD

MannKind Corporation

Approval Confirmed

Afrezza

type 1 and type 2 diabetes

129d ago May 29, 2026

SEC 8-K verified 3mo ago

Countdown card →

MNKD

MannKind Corporation

PDUFA Confirmed

Furoscix ReadyFlow Autoinjector

71d ago Jul 26, 2026

SEC 8-K verified 3mo ago

Countdown card →

MNKD

MannKind Corporation

Phase 1 Confirmed

Nintedanib DPI (MNKD-201)

idiopathic pulmonary fibrosis

T-minus 87 days ~ Dec 31, 2026

SEC 8-K verified 3mo ago

Countdown card →

MNKD

MannKind Corporation

Phase 2 AI-extracted

Afrezza

type 1 or type 2 diabetes

T-minus 452 days ~ Dec 31, 2027

SEC 8-K verified 3mo ago

Countdown card →

MNKD

MannKind Corporation

CRL Confirmed

Afrezza

type 2 diabetes

Date TBD Date TBD

SEC 8-K verified 3mo ago

Countdown card →